Avricore Health (AVCRF) Net Income towards Common Stockholders (2016 - 2025)
Avricore Health has reported Net Income towards Common Stockholders over the past 12 years, most recently at -$321177.9 for Q4 2025.
- Quarterly Net Income towards Common Stockholders rose 76.07% to -$321177.9 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$981968.5 through Dec 2025, up 24.99% year-over-year, with the annual reading at -$981497.4 for FY2025, 26.92% up from the prior year.
- Net Income towards Common Stockholders was -$321177.9 for Q4 2025 at Avricore Health, down from -$275603.9 in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at $125073.5 in Q1 2024 and troughed at -$1.8 million in Q4 2021.
- The 5-year median for Net Income towards Common Stockholders is -$815673.7 (2023), against an average of -$825405.5.
- Year-over-year, Net Income towards Common Stockholders crashed 23215.81% in 2022 and then skyrocketed 109.62% in 2024.
- A 5-year view of Net Income towards Common Stockholders shows it stood at -$1.8 million in 2021, then grew by 8.65% to -$1.6 million in 2022, then increased by 12.12% to -$1.4 million in 2023, then increased by 5.77% to -$1.3 million in 2024, then soared by 76.07% to -$321177.9 in 2025.
- Per Business Quant, the three most recent readings for AVCRF's Net Income towards Common Stockholders are -$321177.9 (Q4 2025), -$275603.9 (Q3 2025), and -$331271.8 (Q2 2025).